60 related articles for article (PubMed ID: 19304675)
1. Prognostic value of 18F-FDG PET in patients with head and neck squamous cell cancer.
Torizuka T; Tanizaki Y; Kanno T; Futatsubashi M; Naitou K; Ueda Y; Ouchi Y
AJR Am J Roentgenol; 2009 Apr; 192(4):W156-60. PubMed ID: 19304675
[TBL] [Abstract][Full Text] [Related]
2. Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survival.
Hassan MZO; Tawakol A; Wang Y; Alvi RM; Awadalla M; Jones-O'Connor M; B Bakar R; Banerji D; Rokicki A; Zhang L; Mulligan CP; Osborne MT; Zarif A; Hammad B; Chan AW; Wirth LJ; Warner ET; Pitman RK; Armstrong KA; Addison D; Neilan TG
PLoS One; 2023; 18(8):e0279235. PubMed ID: 37540647
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing Sarcoma.
Prexler C; Knape MS; Erlewein-Schweizer J; Roll W; Specht K; Woertler K; Weichert W; von Luettichau I; Rossig C; Hauer J; Richter GHS; Weber W; Burdach S
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497479
[TBL] [Abstract][Full Text] [Related]
4. Metabolic parameters on baseline
Kwon HR; Cho J; Park S; Lee SH; Ahn MJ; Choi JY; Lee KH; Jung HA; Moon SH
Front Med (Lausanne); 2022; 9():896494. PubMed ID: 36226146
[TBL] [Abstract][Full Text] [Related]
5. Influence of Semiquantitative [
Cegla P; Currie G; Wróblewska JP; Cholewiński W; Kaźmierska J; Marszałek A; Kubiak A; Golusinski P; Golusiński W; Majchrzak E
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215335
[TBL] [Abstract][Full Text] [Related]
6. Multiple Testing, Cut-Point Optimization, and Signs of Publication Bias in Prognostic FDG-PET Imaging Studies of Head and Neck and Lung Cancer: A Review and Meta-Analysis.
Clausen MM; Vogelius IR; Kjær A; Bentzen SM
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33271785
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of quantitative FDG-PET in the prediction of survival and local recurrence for patients with advanced oral cancer treated with superselective intra-arterial chemoradiotherapy.
Oyama T; Hosokawa Y; Abe K; Hasegawa K; Fukui R; Aoki M; Kobayashi W
Oncol Lett; 2020 Jun; 19(6):3775-3780. PubMed ID: 32382329
[TBL] [Abstract][Full Text] [Related]
8. Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis.
Choi J; Gim JA; Oh C; Ha S; Lee H; Choi H; Im HJ
EJNMMI Res; 2019 Nov; 9(1):97. PubMed ID: 31754877
[TBL] [Abstract][Full Text] [Related]
9. Associations between FDG-PET and Ki 67-index in head and neck cancer: A meta-analysis.
Meyer HJ; Gundermann P; Surov A
Medicine (Baltimore); 2019 Oct; 98(40):e17472. PubMed ID: 31577779
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the malignancy and prognosis of oral squamous cell carcinoma in the maximum standardized uptake value.
Hasegawa O; Satomi T; Kono M; Watanabe M; Ikehata N; Chikazu D
Odontology; 2019 Apr; 107(2):237-243. PubMed ID: 30039234
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study.
Yeh CH; Lin G; Wang JJ; Lin CY; Tsai SY; Lin YC; Wu YM; Ko SF; Wang HM; Chan SC; Yen TC; Liao CT; Ng SH
Oncotarget; 2017 Dec; 8(70):115513-115525. PubMed ID: 29383178
[TBL] [Abstract][Full Text] [Related]
12. Impact and prognostic value of
Riaz S; Bashir H; Iqbal H; Jamshed A; Murtaza A; Hussain R
South Asian J Cancer; 2017; 6(2):81-83. PubMed ID: 28702415
[TBL] [Abstract][Full Text] [Related]
13. [18F]Fluorodeoxyglucose uptake by positron emission tomography predicts outcomes for oropharyngeal and hypopharyngeal cancer treated with definitive radiotherapy.
Ishihara T; Kitajima K; Suenaga Y; Ejima Y; Komatsu H; Otsuki N; Nibu KI; Kiyota N; Takahashi S; Sasaki R
Nagoya J Med Sci; 2017 Feb; 79(1):27-36. PubMed ID: 28303058
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemiotherapy treated head and neck squamous cell carcinoma.
Lombardi M; Cascone T; Guenzi E; Stecco A; Buemi F; Krengli M; Carriero A
Radiol Med; 2017 May; 122(5):345-352. PubMed ID: 28188603
[TBL] [Abstract][Full Text] [Related]
15. Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
Cacicedo J; Navarro A; Del Hoyo O; Gomez-Iturriaga A; Alongi F; Medina JA; Elicin O; Skanjeti A; Giammarile F; Bilbao P; Casquero F; de Bari B; Dal Pra A
Br J Radiol; 2016 Nov; 89(1067):20160217. PubMed ID: 27416996
[TBL] [Abstract][Full Text] [Related]
16. Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.
Kim SG; Friedman K; Patel S; Hagiwara M
AJR Am J Roentgenol; 2016 Aug; 207(2):248-56. PubMed ID: 27163282
[TBL] [Abstract][Full Text] [Related]
17. Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.
Preda L; Conte G; Bonello L; Giannitto C; Travaini LL; Raimondi S; Summers PE; Mohssen A; Alterio D; Cossu Rocca M; Grana C; Ruju F; Bellomi M
Eur Radiol; 2016 Dec; 26(12):4432-4441. PubMed ID: 26965504
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
[TBL] [Abstract][Full Text] [Related]
19. Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation.
Binderup T; Knigge UP; Federspiel B; Sommer P; Hasselby JP; Loft A; Kjaer A
Diagnostics (Basel); 2013 Oct; 3(4):372-84. PubMed ID: 26824929
[TBL] [Abstract][Full Text] [Related]
20. (18)F-FDG PET/CT quantification in head and neck squamous cell cancer: principles, technical issues and clinical applications.
Manca G; Vanzi E; Rubello D; Giammarile F; Grassetto G; Wong KK; Perkins AC; Colletti PM; Volterrani D
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1360-75. PubMed ID: 26780912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
